Gilead Sciences vs Thermo Fisher Scientific

Gilead Sciences (GILD), health care, and Thermo Fisher Scientific (TMO), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Thermo Fisher Scientific is worth $255.6B on the stock market and Gilead Sciences $210.7B: Thermo Fisher Scientific is valued at 21% more. Gilead Sciences's operating margin in its latest fiscal year was 34.0% and Thermo Fisher Scientific's 17.4%. Over the past year Gilead Sciences's share price has moved +31.8% and Thermo Fisher Scientific's +20.0%.

Key facts

Gilead Sciences market value
$210.7B
Thermo Fisher Scientific market value
$255.6B
Thermo Fisher Scientific P/E
36.4
Gilead Sciences revenue
$29.4BFY to 2025-12-31
Thermo Fisher Scientific revenue
$44.6BFY to 2025-12-31
Superinvestors holding both
4

Market values as of .

Gilead Sciences vs Thermo Fisher Scientific: every measure side by side
Measure Gilead Sciences Thermo Fisher Scientific
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$210.7Blower$255.6Bhigher
Revenue$29.4Blower$44.6Bhigher
Earnings$8.5Bhigher$6.7Blower
Employees17,000lower125,000higher
Total assets$59Blower$110.3Bhigher
Valuation
P/E—36.4
P/S7.2higher5.7lower
P/B16.2higher4.7lower
Dividend yield1.94%higher0.27%lower
Profitability
Operating margin34.0%higher17.4%lower
Balance sheet
Net assets$22.7Blower$53.4Bhigher
Total liabilities$36.4Blower$56.8Bhigher
Total debt$24.9Blower$39.4Bhigher
Cash on hand$7.6Blower$9.9Bhigher
Price change
Today+1.39%higher-0.23%lower
1 year+31.8%higher+20.0%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Gilead Sciences / Thermo Fisher Scientific). Who owns GILD · Who owns TMO

Further comparisons

Learn

Questions and answers

Which is bigger, Gilead Sciences or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific is the larger: $255.6B against $210.7B for Gilead Sciences. By revenue in its latest fiscal year, Thermo Fisher Scientific is the larger: $44.6B against $29.4B for Gilead Sciences.

Which has the higher operating margin?

Gilead Sciences: 34.0%, against 17.4% for Thermo Fisher Scientific. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Gilead Sciences: 1.94%, against 0.27% for Thermo Fisher Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Thermo Fisher Scientific: $39.4B, against $24.9B for Gilead Sciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Gilead Sciences and Thermo Fisher Scientific?

In their latest 13F filings, Dodge & Cox team, Steve Cohen, Ken Griffin and David Shaw (founder) hold both.

Cite this page

Funkfolio, “Gilead Sciences vs Thermo Fisher Scientific”, data as of 17 November 2026. https://funkfolio.com/compare/gild-vs-tmo

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.